A new study focused on multiple myeloma, the second most common blood cancer, may lead to better ways to group patients by the state of their DNA and define new subtypes of disease to better predict ...
Hosted on MSN
Lonza cuts DNA-to-IND timelines to 13 months
Lonza has introduced an integrated drug development model that reduces timelines for certain bispecific antibodies from 22–24 months to just 13 months. The approach applies parallel processing, ...
Maternal DNA from Neanderthal teeth found in Stajnia Cave show Neanderthals moved across wide areas of Europe.
MIAMI, FLORIDA (AUG. 20, 2025) – A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood cancer. The findings may lead to better ways to group patients by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results